Sommaire

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A4

    
• • ·Information for Readers

    Page :A5

    

• Editorial

  • ·Heart failure and diabetes: Time to pay attention

    Page :795-797

    David Aguilar

    Plan Plan

• Progress in Cardiology

  • ·LV twisting and untwisting in HCM: Ejection begets filling : Diastolic functional aspects of HCM

    Page :798-810

    Ares Pasipoularides

    Résumé Résumé Plan Plan  

• Trial Design

  • ·The Fixed-dose Combination Drug for Secondary Cardiovascular Prevention project: Improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives

    Page :811

    Ginés Sanz, Valentin Fuster, Luis Guzmán, Antonio Guglietta, Joan Albert Arnáiz, Felipe Martínez, Antonio Sarria, Maria Carla Roncaglioni, Kathryn Taubert

    Résumé Résumé Plan Plan  
  • ·The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus–Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 Study

    Page :818

    Benjamin M. Scirica, Deepak L. Bhatt, Eugene Braunwald, Ph. Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Deborah L. Price, Roland Chen, Jacob Udell, Itamar Raz

    Résumé Résumé Plan Plan  
  • ·Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-site

    Page :826-831

    Laura Mauri, Sharon-Lise T. Normand, Michael Pencina, Donald E. Cutlip, Cathy Jeon, Paul Dreyer, Richard E. Kuntz, Donald S. Baim, Alice K. Jacobs

    Résumé Résumé Plan Plan  

• Essays From the Front Lines of Health Care

  • ·The first call from Dad

    Page :832-835

    Maurice R. “Pat” Berdan, Lisa G. Berdan

     

• Clinical Investigations

  • ·Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and ?-blockers after coronary artery bypass graft surgery

    Page :836-843

    Dimitri Kalavrouziotis, Karen J. Buth, Jafna L. Cox, Roger J. Baskett

    Résumé Résumé Plan Plan  
  • ·Treatment with Adenosine Diphosphate Receptor Inhibitors—Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study design: Expanding the paradigm of longitudinal observational research

    Page :844-851

    Chee Tang Chin, Tracy Y. Wang, Kevin J. Anstrom, Baojin Zhu, Jen-Fue Maa, John C. Messenger, Kelley A. Ryan, Linda Davidson-Ray, Marjorie Zettler, Mark B. Effron, Daniel B. Mark, Eric D. Peterson

    Résumé Résumé Plan Plan  
  • ·Management of acute coronary syndromes in developing countries: ACute Coronary Events—a multinational Survey of current management Strategies

    Page :852

    The ACCESS Investigators a b ?

    Résumé Résumé Plan Plan  
  • ·Cognitive impairment and outcomes in older adult survivors of acute myocardial infarction: Findings from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health Status registry

    Page :860

    S. Michael Gharacholou, Kimberly J. Reid, Suzanne V. Arnold, John Spertus, Michael W. Rich, Patricia A. Pellikka, Mandeep Singh, Tracey Holsinger, Harlan M. Krumholz, Eric D. Peterson, Karen P. Alexander

    Résumé Résumé Plan Plan  
  • ·Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: A double-blind, randomized trial

    Page :870-874

    Prabowo Tunggal, Fook-Hong Ng, Kwok-Fai Lam, Francis K.L. Chan, Yuk-Kong Lau

    Résumé Résumé Plan Plan  
  • ·Predicting long-term mortality in older patients after non–ST-segment elevation myocardial infarction: The CRUSADE long-term mortality model and risk score

    Page :875

    Matthew T. Roe, Anita Y. Chen, Laine Thomas, Tracy Y. Wang, Karen P. Alexander, Bradley G. Hammill, W. Brian Gibler, E. Magnus Ohman, Eric D. Peterson

    Résumé Résumé Plan Plan  
  • ·Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function

    Page :884

    Chiara Melloni, Stefan K. James, Jennifer A. White, Robert P. Giugliano, Robert A. Harrington, Kurt Huber, Pierluigi Tricoci, Paul W. Armstrong, Frans Van de Werf, Gilles Montalescot, Robert M. Califf, L. Kristin Newby

    Résumé Résumé Plan Plan  
  • ·Myeloperoxidase in the diagnosis of acute coronary syndromes: The importance of spectrum

    Page :893-899

    W. Frank Peacock, John Nagurney, Robert Birkhahn, Adam Singer, Nathan Shapiro, Judd Hollander, Ted Glynn, Richard Nowak, Basmah Safdar, Chadwick Miller, Mary Peberdy, Francis Counselman, Abhinav Chandra, Joshua Kosowsky, James Neuenschwander, Jon Schrock, Stephen Plantholt, Elizabeth Lewandrowski, Vance Wong, Ken Kupfer, Deborah Diercks

    Résumé Résumé Plan Plan  
  • ·Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

    Page :900-906

    Cono A. Ariti, John G.F. Cleland, Stuart J. Pocock, Marc A. Pfeffer, Karl Swedberg, Christopher B. Granger, John J.V. McMurray, Eric L. Michelson, Jan Östergren, Salim Yusuf

    Résumé Résumé Plan Plan  
  • ·Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting

    Page :907-913

    Etienne Puymirat, Fabio Mangiacapra, Aaron Peace, Faisal Sharif, Micaela Conte, Jozef Bartunek, Marc Vanderheyden, William Wijns, Bernard de Bruyne, Emanuele Barbato

    Résumé Résumé Plan Plan  
  • ·Mode of death after contemporary percutaneous coronary intervention: A report from the Evaluation of Drug Eluting Stents and Ischemic Events registry

    Page :914-921

    Joshua M. Stolker, David J. Cohen, Jason B. Lindsey, Kevin F. Kennedy, Neal S. Kleiman, Steven P. Marso

    Résumé Résumé Plan Plan  
  • ·Long-term tissue coverage of a biodegradable polylactide polymer–coated biolimus-eluting stent: Comparative sequential assessment with optical coherence tomography until complete resorption of the polymer

    Page :922-931

    Juan Luis Gutiérrez-Chico, Peter Jüni, Héctor M. García-García, Evelyn Regar, Eveline Nüesch, Francesco Borgia, Willem J. van der Giessen, Simon Davies, Robert Jan van Geuns, Gioel Gabrio Secco, Susanne Meis, Stephan Windecker, Patrick W. Serruys, Carlo di Mario

    Résumé Résumé Plan Plan  
  • ·Trends in the use of diagnostic coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft surgery across North Carolina

    Page :932-937

    W. Schuyler Jones, Manesh R. Patel, Sara A. Holleran, J. Kevin Harrison, Christopher M. O'Connor, Harry R. Phillips

    Résumé Résumé Plan Plan  
  • ·Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: Evidence from a 37,229 patient meta-analysis

    Page :938

    Davide Castagno, Jonathan Baird-Gunning, Pardeep S. Jhund, Giuseppe Biondi-Zoccai, Michael R. MacDonald, Mark C. Petrie, Fiorenzo Gaita, John J.V. McMurray

    Résumé Résumé Plan Plan  
  • ·Effect of controlled reduction of body iron stores on clinical outcomes in peripheral arterial disease

    Page :949

    Leo R. Zacharski, Galina Shamayeva, Bruce K. Chow

    Résumé Résumé Plan Plan  

• Letter to the Editor

  • ·Delayed arterial healing 5 years after implantation of sirolimus-eluting stents: No smoke without fire

    Page :e29

    Wail Nammas